HeartSciences (HSCS) Competitors $3.73 -0.02 (-0.53%) Closing price 10/7/2025 04:00 PM EasternExtended Trading$3.63 -0.10 (-2.68%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HSCS vs. MLSS, CLGN, POCI, RBOT, PETV, STRR, NRXS, RVP, VVOS, and NXGLShould you be buying HeartSciences stock or one of its competitors? The main competitors of HeartSciences include Milestone Scientific (MLSS), CollPlant Biotechnologies (CLGN), Precision Optics (POCI), Vicarious Surgical (RBOT), PetVivo (PETV), Star Equity (STRR), NeurAxis (NRXS), Retractable Technologies (RVP), Vivos Therapeutics (VVOS), and NexGel (NXGL). These companies are all part of the "medical equipment" industry. HeartSciences vs. Its Competitors Milestone Scientific CollPlant Biotechnologies Precision Optics Vicarious Surgical PetVivo Star Equity NeurAxis Retractable Technologies Vivos Therapeutics NexGel Milestone Scientific (NYSE:MLSS) and HeartSciences (NASDAQ:HSCS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership. Which has more volatility & risk, MLSS or HSCS? Milestone Scientific has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500. Comparatively, HeartSciences has a beta of 2.57, indicating that its share price is 157% more volatile than the S&P 500. Which has better earnings & valuation, MLSS or HSCS? Milestone Scientific has higher revenue and earnings than HeartSciences. Milestone Scientific is trading at a lower price-to-earnings ratio than HeartSciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMilestone Scientific$9.08M3.91-$6.93M-$0.09-5.02HeartSciencesN/AN/A-$8.77M-$8.30-0.45 Is MLSS or HSCS more profitable? HeartSciences has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Milestone Scientific's return on equity of -60.26% beat HeartSciences' return on equity.Company Net Margins Return on Equity Return on Assets Milestone Scientific-52.01% -60.26% -40.23% HeartSciences N/A -383.38%-145.28% Do insiders & institutionals have more ownership in MLSS or HSCS? 5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 17.2% of HeartSciences shares are owned by institutional investors. 24.8% of Milestone Scientific shares are owned by company insiders. Comparatively, 1.8% of HeartSciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts prefer MLSS or HSCS? Milestone Scientific currently has a consensus target price of $1.25, indicating a potential upside of 176.61%. HeartSciences has a consensus target price of $10.50, indicating a potential upside of 181.50%. Given HeartSciences' higher probable upside, analysts clearly believe HeartSciences is more favorable than Milestone Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Milestone Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00HeartSciences 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the media prefer MLSS or HSCS? In the previous week, HeartSciences had 4 more articles in the media than Milestone Scientific. MarketBeat recorded 4 mentions for HeartSciences and 0 mentions for Milestone Scientific. Milestone Scientific's average media sentiment score of 0.00 beat HeartSciences' score of -0.34 indicating that Milestone Scientific is being referred to more favorably in the media. Company Overall Sentiment Milestone Scientific Neutral HeartSciences Neutral SummaryMilestone Scientific beats HeartSciences on 8 of the 15 factors compared between the two stocks. Get HeartSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HSCS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSCS vs. The Competition Export to ExcelMetricHeartSciencesMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.93M$2.26B$6.11B$10.65BDividend YieldN/AN/A5.70%4.74%P/E Ratio-0.4537.1985.8226.85Price / SalesN/A12.34616.35135.13Price / CashN/A61.3337.7861.77Price / Book20.7212.7713.236.70Net Income-$8.77M-$63.46M$3.30B$276.44M7 Day Performance4.48%3.26%3.91%2.48%1 Month Performance12.01%4.60%8.38%8.79%1 Year Performance-8.13%43.78%88.63%34.41% HeartSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSCSHeartSciences2.1169 of 5 stars$3.73-0.5%$10.50+181.5%-16.4%$9.93MN/A-0.4510Gap DownMLSSMilestone Scientific2.8852 of 5 stars$0.45-0.4%$1.25+175.1%-48.8%$35.69M$9.08M-6.4930CLGNCollPlant Biotechnologies2.3732 of 5 stars$2.69-12.9%$11.50+327.5%-54.1%$34.22M$510K-2.3870News CoveragePositive NewsGap DownHigh Trading VolumePOCIPrecision Optics0.5709 of 5 stars$4.35-0.9%N/A-6.7%$33.35M$17.63M-4.8980High Trading VolumeRBOTVicarious Surgical1.05 of 5 stars$5.50+1.7%$7.00+27.3%+7.0%$32.62MN/A-0.55210PETVPetVivoN/A$1.10+6.8%N/A+120.3%$32.17M$1.05M-2.4420News CoverageGap DownSTRRStar Equity1.1476 of 5 stars$11.12-0.4%$5.00-55.0%+179.9%$30.69M$140.06M-8.551,300Positive NewsNRXSNeurAxis2.0013 of 5 stars$3.08-1.0%$7.00+127.3%-1.2%$30.41M$3.22M-1.6719RVPRetractable Technologies1.541 of 5 stars$0.84+2.7%N/A+24.3%$25.21M$38.16M-1.56240Gap DownVVOSVivos Therapeutics1.9459 of 5 stars$3.10-1.0%$4.92+58.6%+28.1%$23.25M$15.03M-1.85160High Trading VolumeNXGLNexGel0.9487 of 5 stars$2.44+0.7%N/A+2.4%$19.65M$11.67M-6.0910News Coverage Related Companies and Tools Related Companies Milestone Scientific Competitors CollPlant Biotechnologies Competitors Precision Optics Competitors Vicarious Surgical Competitors PetVivo Competitors Star Equity Competitors NeurAxis Competitors Retractable Technologies Competitors Vivos Therapeutics Competitors NexGel Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSCS) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | Sponsored"I'm risking my reputation on this"My prediction: Q4 2025 won't just be another seasonal crypto pump. It will be the quarter that sparks a crypto...Crypto 101 Media | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HeartSciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HeartSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
